MyFinsight
Home
Blog
About
Contact
Download
Download image
Med Tech
$8,801M
Innovative Medicine
$15,763M
Sales to customers
$24,564M
Interest income
$237M
Gross profit
$16,596M
Cost of products sold
$7,968M
Effective rate
-$150M
Earnings before
provision for taxes on...
$4,966M
Restructuring
$84M
Other (income)
expense, net
-$483M
Interest expense, net of
portion capitalized
$214M
In-process research and
development impairments
$32M
Research and development
expense
$4,252M
Selling, marketing and
administrative expenses
$6,753M
Net earnings from
continuing operations
$5,116M
Net earnings
$5,116M
Back
Back
Income Statement
source: myfinsight.com
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)